Literature DB >> 21159944

Can we use imipenem and meropenem Vitek 2 MICs for detection of suspected KPC and other-carbapenemase producers among species of Enterobacteriaceae?

Fernando Pasteran1, Celeste Lucero, Rolando Soloaga, Melina Rapoport, Alejandra Corso.   

Abstract

Imipenem and meropenem Vitek 2 MICs were evaluated for a panel of 104 Enterobacteriaceae for identification of carbapenemase producers. The sensitivity and specificity values for the new CLSI interpretative criteria (CLSI document M100-S20-U, 2010) were 98% and 83% for imipenem and 76% and 83% for meropenem, respectively. We propose an algorithm that is highly sensitive (98%) and specific (94%) for carbapenemase screening based on the combined use of imipenem and meropenem MICs.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21159944      PMCID： PMC3043475          DOI： 10.1128/JCM.01178-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  24 in total

1.  CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

2.  Do CTX-M beta-lactamases hydrolyse ertapenem?

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2008-07-28       Impact factor: 5.790

3.  Specificity of ertapenem susceptibility screening for detection of Klebsiella pneumoniae carbapenemases.

Authors:  Shannon E McGettigan; Kathleen Andreacchio; Paul H Edelstein
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

4.  A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin.

Authors:  C G Giske; L Gezelius; Ø Samuelsen; M Warner; A Sundsfjord; N Woodford
Journal:  Clin Microbiol Infect       Date:  2011-04       Impact factor: 8.067

5.  Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory.

Authors:  Neil Woodford; John W T Dallow; Robert L R Hill; Marie-France I Palepou; Rachel Pike; M Elaina Ward; Marina Warner; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2007-02-12       Impact factor: 5.283

6.  Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.

Authors:  Simona Bratu; Mohamad Mooty; Satyen Nichani; David Landman; Carl Gullans; Barbara Pettinato; Usha Karumudi; Pooja Tolaney; John Quale
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.

Authors:  Michel Doumith; Matthew J Ellington; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2009-02-20       Impact factor: 5.790

8.  Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.

Authors:  K F Anderson; D R Lonsway; J K Rasheed; J Biddle; B Jensen; L K McDougal; R B Carey; A Thompson; S Stocker; B Limbago; J B Patel
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

9.  Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.

Authors:  Fred C Tenover; Rajinder K Kalsi; Portia P Williams; Roberta B Carey; Sheila Stocker; David Lonsway; J Kamile Rasheed; James W Biddle; John E McGowan; Bruce Hanna
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

10.  Ertapenem resistance of Escherichia coli.

Authors:  Marie-Frédérique Lartigue; Laurent Poirel; Claire Poyart; Hélène Réglier-Poupet; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883
View more
  5 in total

1.  Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints.

Authors:  David Landman; Julius Salamera; Manisha Singh; John Quale
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

2.  Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems.

Authors:  N Y Lee; J J Wu; S H Lin; W C Ko; L H Tsai; J J Yan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-18       Impact factor: 3.267

3.  Evaluation of carbapenemase screening and confirmation tests with Enterobacteriaceae and development of a practical diagnostic algorithm.

Authors:  Florian P Maurer; Claudio Castelberg; Chantal Quiblier; Guido V Bloemberg; Michael Hombach
Journal:  J Clin Microbiol       Date:  2014-10-29       Impact factor: 5.948

Review 4.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

5.  A locked nucleic acid (LNA)-based real-time PCR assay for the rapid detection of multiple bacterial antibiotic resistance genes directly from positive blood culture.

Authors:  Lingxiang Zhu; Dingxia Shen; Qiming Zhou; Zexia Li; Xiangdong Fang; Quan-Zhen Li
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.